Back
Ultragenyx Pharmaceutical, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
5
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$22.78
Seasonality Move:
-4.15%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and RARE is experiencing slight buying pressure.
Ultragenyx Pharmaceutical, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.12 | Sell |
| 20-day SMA: | 34.24 | Sell |
| 50-day SMA: | 33.63 | Sell |
| 200-day SMA: | 33.39 | Sell |
| 8-day EMA: | 26.34 | Sell |
| 20-day EMA: | 17.36 | Buy |
| 50-day EMA: | 8.73 | Buy |
| 200-day EMA: | 2.46 | Buy |
Ultragenyx Pharmaceutical, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.33 | Buy |
| Relative Strength Index (14 RSI): | 18.5 | Sell |
| Chaikin Money Flow: | 5633594 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.92 - 37.34) | Sell |
| Bollinger Bands (100): | (29.14 - 34.56) | Sell |
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical, Inc. Stock
Is Ultragenyx Pharmaceutical, Inc. Stock a Buy?
-
Ultragenyx Pharmaceutical, Inc. share price is 19.72 while RARE 8-day simple moving average is 32.12, which is a Sell signal.
-
The stock price of RARE is 19.72 while Ultragenyx Pharmaceutical, Inc. 20-day SMA is 34.24, which makes it a Sell.
-
Ultragenyx Pharmaceutical, Inc. 50-day simple moving average is 33.63 while RARE share price is 19.72, making it a Sell technically.
-
RARE stock price is 19.72 and Ultragenyx Pharmaceutical, Inc. 200-day simple moving average is 33.39, creating a Sell signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
5
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy or a Sell?
-
Ultragenyx Pharmaceutical, Inc. stock is rated a SellThe current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $19.72. The Score for RARE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical, Inc. Stock Info
Market Cap:
1.9B
Price in USD:
19.72
Share Volume:
21.7M
Ultragenyx Pharmaceutical, Inc. 52-Week Range
52-Week High:
46.50
52-Week Low:
18.41
Sell
5
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Ultragenyx Pharmaceutical, Inc. Share Price Forecast
-
What is the Ultragenyx Pharmaceutical, Inc. stock price today?The Ultragenyx Pharmaceutical, Inc. stock price is 19.72 USD today.
-
Will RARE stock go up or go down?Ultragenyx Pharmaceutical, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Ultragenyx Pharmaceutical, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical, Inc. is overvalued.
Is Ultragenyx Pharmaceutical, Inc. Stock a Buy?
-
Ultragenyx Pharmaceutical, Inc. share price is 19.72 while RARE 8-day exponential moving average is 26.34, which is a Sell signal.
-
The stock price of RARE is 19.72 while Ultragenyx Pharmaceutical, Inc. 20-day EMA is 17.36, which makes it a Buy.
-
Ultragenyx Pharmaceutical, Inc. 50-day exponential moving average is 8.73 while RARE share price is 19.72, making it a Buy technically.
-
RARE stock price is 19.72 and Ultragenyx Pharmaceutical, Inc. 200-day simple moving average is 2.46, creating a Buy signal.
Fundamental Analysis of Ultragenyx Pharmaceutical, Inc.
Is Ultragenyx Pharmaceutical, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $1.44 per share.
Technical Analysis of Ultragenyx Pharmaceutical, Inc.
Should I short Ultragenyx Pharmaceutical, Inc. stock?
-
RARE Moving Average Covergence Divergence (MACD) indicator is 8.33, suggesting Ultragenyx Pharmaceutical, Inc. is a Buy
-
Ultragenyx Pharmaceutical, Inc. Relative Strength Index (RSI) is 18.5, which suggest Ultragenyx Pharmaceutical, Inc. is oversold
-
The Bollinger Bands (25) for Ultragenyx Pharmaceutical, Inc. is (30.92 - 37.34), which suggest Ultragenyx Pharmaceutical, Inc. is a Sell
-
The Bollinger Bands (100) for Ultragenyx Pharmaceutical, Inc. is (29.14 - 34.56), which suggest Ultragenyx Pharmaceutical, Inc. is a Sell
* Ultragenyx Pharmaceutical, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.